# A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer

> **NCT05154487** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **GOG Foundation** · enrollment: 51 (estimated)

## Conditions studied

- Endometroid Endometrial Cancer

## Interventions

- **DRUG:** Alpelisib Pill
- **DRUG:** Fulvestrant injection

## Key facts

- **NCT ID:** NCT05154487
- **Lead sponsor:** GOG Foundation
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-09-11
- **Primary completion:** 2028-05-01
- **Final completion:** 2028-11-01
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2026-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05154487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05154487, "A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05154487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*